159837 生物科技
已收盘 05-22 15:00:00
资讯
新帖
简况
YZi Labs 开放 EASY Residency S4 孵化申请，聚焦 Web3、AI 和生物科技
链捕手 · 05-22 17:03
YZi Labs 开放 EASY Residency S4 孵化申请，聚焦 Web3、AI 和生物科技
【ETF动向】5月21日生物科技ETF易方达基金涨0.65%，份额增加1.17亿份
证券之星 · 05-22 08:32
【ETF动向】5月21日生物科技ETF易方达基金涨0.65%，份额增加1.17亿份
万联证券：2026Q1公募医药持仓向创新产业链集中 建议关注生物科技公司及大型药企
智通财经 · 05-13
万联证券：2026Q1公募医药持仓向创新产业链集中 建议关注生物科技公司及大型药企
港交所生物科技上市改革成效显著：已有86家公司通过18A上市 市值超1850亿美元
智通财经 · 05-12
港交所生物科技上市改革成效显著：已有86家公司通过18A上市 市值超1850亿美元
李氏大药厂(00950)拟斥资2500万元参投生命健康产业基金 布局生物科技赛道
智通财经 · 05-11
李氏大药厂(00950)拟斥资2500万元参投生命健康产业基金 布局生物科技赛道
12家递表，多家生物科技公司齐招股、上市｜港股IPO周报
21世纪经济报道 · 05-10
12家递表，多家生物科技公司齐招股、上市｜港股IPO周报
大成生化科技(00809)附属就生产辅酶Q10菌丝体与神舟生物科技订立合作协议
智通财经 · 05-08
大成生化科技(00809)附属就生产辅酶Q10菌丝体与神舟生物科技订立合作协议
易方达中证生物科技主题ETF发起式联接A基金经理变动：增聘陈英嘉为基金经理
证券之星 · 04-11
易方达中证生物科技主题ETF发起式联接A基金经理变动：增聘陈英嘉为基金经理
圣湘生物（688289）披露关于与关联方共同投资华斯无微生物科技（深圳）有限公司的议案，4月3日股价下跌2.63%
证券之星 · 04-03
圣湘生物（688289）披露关于与关联方共同投资华斯无微生物科技（深圳）有限公司的议案，4月3日股价下跌2.63%
诚益通：公司3月份收到黑龙江伊品生物科技有限公司45万吨氨基酸及配套加工项目淀粉、制糖车间安装工程（ZTAZ-1标）项目中标通知书
证券之星 · 04-01
诚益通：公司3月份收到黑龙江伊品生物科技有限公司45万吨氨基酸及配套加工项目淀粉、制糖车间安装工程（ZTAZ-1标）项目中标通知书
美股异动丨生物科技公司Centessa暴涨近46%，获礼来以高达78亿美元的价格收购
格隆汇 · 03-31
美股异动丨生物科技公司Centessa暴涨近46%，获礼来以高达78亿美元的价格收购
每周股票复盘：安琪酵母（600298）投建白洋生物科技园二期
证券之星 · 03-22
每周股票复盘：安琪酵母（600298）投建白洋生物科技园二期
艾科联生物科技完成数千万美元融资 |【经纬低调新闻】
经纬创投 · 03-19
艾科联生物科技完成数千万美元融资 |【经纬低调新闻】
公告精选︱安琪酵母：宜昌高新区公司拟7.97亿元实施白洋生物科技园项目二期；顺灏股份：轨道辰光的“天数天算”业务可能在未来5年内才有明确的商业价值
格隆汇 · 03-18
公告精选︱安琪酵母：宜昌高新区公司拟7.97亿元实施白洋生物科技园项目二期；顺灏股份：轨道辰光的“天数天算”业务可能在未来5年内才有明确的商业价值
安琪酵母最新公告：拟投建白洋生物科技园项目二期
证券之星 · 03-18
安琪酵母最新公告：拟投建白洋生物科技园项目二期
步长制药（603858）披露控股子公司拟转让湖南众测生物科技60%股权公告，3月17日股价上涨0.12%
证券之星 · 03-17
步长制药（603858）披露控股子公司拟转让湖南众测生物科技60%股权公告，3月17日股价上涨0.12%
港股异动 | 正大企业国际(03839)午后涨近14% 拟更名为“正大生物”生物科技业务贡献全部收入
智通财经 · 03-17
港股异动 | 正大企业国际(03839)午后涨近14% 拟更名为“正大生物”生物科技业务贡献全部收入
华润医药(03320)：华润医药投资拟挂牌出售天麦生物科技约5.88%股权
智通财经 · 03-16
华润医药(03320)：华润医药投资拟挂牌出售天麦生物科技约5.88%股权
新股消息 | 传生物科技初创公司Earendil Labs拟赴港IPO 融资规模或高达5亿美元
智通财经 · 03-13
新股消息 | 传生物科技初创公司Earendil Labs拟赴港IPO 融资规模或高达5亿美元
香港交易所罗博仁：今年香港生物科技行业增长动力依然稳固
智通财经 · 03-06
香港交易所罗博仁：今年香港生物科技行业增长动力依然稳固
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159837","market":"SZ","secType":"STK","nameCN":"生物科技","latestPrice":0.459,"timestamp":1779433404000,"preClose":0.466,"halted":0,"volume":86618110,"delay":0,"changeRate":-0.015,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.007,"latestTime":"05-22 15:00:00","open":0.467,"high":0.468,"low":0.456,"amount":39789200,"amplitude":0.0258,"askPrice":0.459,"askSize":6709,"bidPrice":0.458,"bidSize":4444,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779672600000},"marketStatusCode":5,"adr":0,"adjPreClose":0.466,"symbolType":"fund","openAndCloseTimeList":[[1779413400000,1779420600000],[1779426000000,1779433200000]],"highLimit":0.513,"lowLimit":0.419,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":0.297112,"marketValue":0,"turnoverRate":0,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-05-26。","floatMarketCap":0},"requestUrl":"/m/hq/s/159837","defaultTab":"news","newsList":[{"id":"2637397719","title":"YZi Labs 开放 EASY Residency S4 孵化申请，聚焦 Web3、AI 和生物科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2637397719","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637397719?lang=zh_cn&edition=full","pubTime":"2026-05-22 17:03","pubTimestamp":1779440597,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，YZi Labs 宣布启动其旗舰全球孵化项目 EASY Residency 第四季（S4），申请截止时间为 6 月 21 日。此次为期 10 周的创始人项目采用“5 周线上 + 5 周不丹线下”的模式，其线下阶段将在不丹新设立的特殊行政区格莱普正念城进行。入选项目最高可获得 50 万美元投资，包含 15 万美元换取 5% 股权的 SAFE 协议以及 350 万美元无上限的 SAFE 协议，且创始人在不丹期间的住宿、餐饮及工作空间费用全免。\n\n此轮孵化重点关注 Web3、AI 以及生物技术领域，包括全球支付、智能体经济（Agentic Economy）、下一代 DeFi、AI 基础设施、AI × 医疗生物以及 Web3 × 医疗生物等。导师阵容包括赵长鹏、何一及 Balaji 等。 ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2266587","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","AGIX","159837","ARTY","XBI","BK4581","EASY","AIPO","HBImain","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365440","title":"【ETF动向】5月21日生物科技ETF易方达基金涨0.65%，份额增加1.17亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637365440?lang=zh_cn&edition=full","pubTime":"2026-05-22 08:32","pubTimestamp":1779409936,"startTime":"0","endTime":"0","summary":"证券之星消息，5月21日，生物科技ETF易方达基金（159837）涨0.65%，成交额9934.29万元。当日份额增加了1.17亿份，最新份额为31.22亿份，近20个交易日份额增加2.48亿份。当日资金净流入6376.78万元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为14.53亿元。生物科技ETF易方达基金跟踪标的为中证生物科技主题指数，成立（2021-01-14）以来超额回报为2.32%，近一个月超额回报为0.23%，管理人为易方达基金公司，基金经理为张湛 陈英嘉。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200008618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["HBImain","159837"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635682278","title":"万联证券：2026Q1公募医药持仓向创新产业链集中 建议关注生物科技公司及大型药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2635682278","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635682278?lang=zh_cn&edition=full","pubTime":"2026-05-13 10:15","pubTimestamp":1778638552,"startTime":"0","endTime":"0","summary":"万联证券主要观点如下：截至2026Q1，医药主题基金规模环比增加59.90亿元医药生物占所有行业重仓总市值的百分比环比增加0.90个百分点，生物制品和医疗服务重仓总市值环比增加较多，公募基金医药持仓结构继续向创新药及CXO等创新产业链集中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HBImain","09939","BK4588","BK1515","BK1161","BK4581","XBI","BK4585","159837","161027","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634213441","title":"港交所生物科技上市改革成效显著：已有86家公司通过18A上市 市值超1850亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634213441","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634213441?lang=zh_cn&edition=full","pubTime":"2026-05-12 19:13","pubTimestamp":1778584387,"startTime":"0","endTime":"0","summary":"新规生效以来，已有86家生物科技公司透过该制度上市，集资总额超过178亿美元。截至2026年4月16日，这些公司市值合计超过1850亿美元。截至2026年4月，在香港交易所上市的生物科技及医疗保健相关公司已超过276家，合计市值逾5万亿港元。按NextPharma数据，2025年涉及中国创新药对外授权交易总值达1,360亿美元。随着投资者对生物科技ETF的兴趣显著升温，香港上市生物科技ETF的资产管理规模，已由2021年3月的15亿港元，大幅增至2026年3月底的120亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440806.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","159837","HEXmain","IPOS","BK4581","BK4585","HBImain","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634280989","title":"李氏大药厂(00950)拟斥资2500万元参投生命健康产业基金 布局生物科技赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2634280989","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634280989?lang=zh_cn&edition=full","pubTime":"2026-05-11 22:26","pubTimestamp":1778509575,"startTime":"0","endTime":"0","summary":"李氏大药厂(00950)公布，于2026年5月11日，公司的间接全资附属公司兆科合肥、普通合伙人瑞伏博健及其他有限合伙人订立有限合伙协议，据此，该等合伙人向基金出资人民币2亿元，而兆科合肥同意向基金出资人民币2500万元，相当于约12.5%基金权益。基金的目的为寻求投资于生命与健康、生物科技及相关上下游行业的非上市实体，符合公司的业务策略，透过于医药领域的策略合伙、投资及收购加强业务。投资基金符合集团的核心策略，透过具影响力的合伙及收购扩大其医药及保健版图。借认购基金的有限合伙权益，该集团得以间接涉足生物科技及生命科学领域的非上市实体的高增长，善用普通合伙人深厚的行业知识。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159837","HBImain","BK4588","BK1574","BK1191","BK4585","00950","BK1583","06622","XBI","BK1587","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634844328","title":"12家递表，多家生物科技公司齐招股、上市｜港股IPO周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2634844328","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634844328?lang=zh_cn&edition=full","pubTime":"2026-05-10 09:59","pubTimestamp":1778378340,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者 吴歌Wind数据显示，5月4日—5月10日，当周有12家公司向港交所递表，2家公司通过聆讯，3家公司持续招股，2家公司成功挂牌上市。此外，还有天星医疗、可孚医疗两只医疗领域新股纷纷上市。本周共有12家公司向港交所递表：5月4日，江西生物向港交所主板提交上市申请，中金公司及招商证券国际担任联席保荐人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-05-10/doc-inhxkper7882466.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-05-10/doc-inhxkper7882466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SPCX","BK4581","VXUS","BK4588","BK4585","IPOS","XBI","159837","HBImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633391434","title":"大成生化科技(00809)附属就生产辅酶Q10菌丝体与神舟生物科技订立合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2633391434","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633391434?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:26","pubTimestamp":1778232395,"startTime":"0","endTime":"0","summary":"智通财经APP讯，大成生化科技 发布公告，本公司间接全资附属公司长春大成大合生物技术开发有限公司与神舟生物科技有限责任公司订立合作协议，据此，神舟生物科技同意委聘大成大合生产辅酶Q10菌丝体。双方亦协定，在神舟生物科技对产品检验合格后，神舟生物科技将根据其月度采购计划向大成大合采购辅酶Q10菌丝体，于2027年1月1日至2028年12月31日期间的最低采购量为1270公吨辅酶Q10。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1212","BK4588","BK4585","XBI","159837","BK4581","00809","HBImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626155141","title":"易方达中证生物科技主题ETF发起式联接A基金经理变动：增聘陈英嘉为基金经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2626155141","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626155141?lang=zh_cn&edition=full","pubTime":"2026-04-11 09:31","pubTimestamp":1775871119,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年4月11日，易方达中证生物科技主题ETF联接发起式发布公告，增聘陈英嘉为基金经理，任职日期自2026年4月11日起，李栩不再担任该基金基金经理，离任日期为2026年4月11日，变更后易方达中证生物科技主题ETF联接发起式的基金经理为陈英嘉。截止2026年4月10日，易方达中证生物科技主题ETF联接发起式净值为0.9457，较上一日上涨0.8%，近一年上涨11.19%。2026年3月5日起任易方达中证生物科技主题交易型开放式指数证券投资基金基金经理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041100006188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["HBImain","159837"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624591736","title":"圣湘生物（688289）披露关于与关联方共同投资华斯无微生物科技（深圳）有限公司的议案，4月3日股价下跌2.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624591736","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624591736?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:40","pubTimestamp":1775209229,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，圣湘生物报收于17.76元，较前一交易日下跌2.63%，最新总市值为102.9亿元。该股当日开盘18.19元，最高18.22元，最低17.75元，成交额达7054.79万元，换手率为0.68%。公告显示，公司于2026年3月31日召开2026年第一次临时股东会，审议通过《关于与关联方共同投资华斯无微生物科技（深圳）有限公司的议案》。关联股东未出席本次会议。湖南启元律师事务所对本次会议进行了见证并出具法律意见书，认为会议决议合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["HBImain","BK0239","688289","159837"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624560898","title":"诚益通：公司3月份收到黑龙江伊品生物科技有限公司45万吨氨基酸及配套加工项目淀粉、制糖车间安装工程（ZTAZ-1标）项目中标通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2624560898","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624560898?lang=zh_cn&edition=full","pubTime":"2026-04-01 15:00","pubTimestamp":1775026842,"startTime":"0","endTime":"0","summary":"证券之星消息，诚益通03月31日在投资者关系平台上答复投资者关心的问题。诚益通回复：尊敬的投资者您好，公司3月份收到黑龙江伊品生物科技有限公司45万吨氨基酸及配套加工项目淀粉、制糖车间安装工程项目中标通知书，中标金额为1775.57万元，目前暂未签订合同，签订合同日期以实际签约时间为准。该项目金额未达到重大合同披露标准。如达到信息披露标准，公司将按法律法规要求进行披露，请您关注公司公告。再次感谢您的建议和支持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100021937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159837","BK0130","300430","BK0028","HBImain","BK0225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623071538","title":"美股异动丨生物科技公司Centessa暴涨近46%，获礼来以高达78亿美元的价格收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2623071538","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623071538?lang=zh_cn&edition=full","pubTime":"2026-03-31 23:09","pubTimestamp":1774969770,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"044b49fac9463464d2e44ed274e1a9ed","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4534","LU0787776722.HKD","LU2168564149.EUR","SG9999013999.USD","LU0786609619.USD","LU1989771016.USD","LU0353189680.USD","LU0823434583.USD","159837","LU1069344957.HKD","LLYX","LU1023059063.AUD","LU2602419157.SGD","LU2756315664.SGD","LU2471134952.CNY","LU0354030511.USD","LU2111349929.HKD","LU0471298694.HKD","LU0353189763.USD","ELIS","LU2023250504.SGD","LU0058720904.USD","LU1093756325.SGD","LU0820562030.AUD","SGXZ99366536.SGD","LLII","LU1623119135.USD","LU2271345857.HKD","LU2361044865.SGD","LLY","LU0158827948.USD","ELIL","LU1804176565.USD","LU1280957306.USD","LU1974910355.USD","LU0316494557.USD","LU2361044949.HKD","SG9999015952.SGD","BK4599","IE00B7KXQ091.USD","LLYZ","LU2023250330.USD","XBI","BK4533","LU0079474960.USD","LU0820561818.USD","HBImain","LU0889565916.HKD","IE00BJJMRX11.SGD","LU0266013472.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621796084","title":"每周股票复盘：安琪酵母（600298）投建白洋生物科技园二期","url":"https://stock-news.laohu8.com/highlight/detail?id=2621796084","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621796084?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:26","pubTimestamp":1774117573,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，安琪酵母报收于40.17元，较上周的42.09元下跌4.56%。本周，安琪酵母3月16日盘中最高价报42.3元。本周关注点公司公告汇总：安琪酵母拟投资79,739万元实施白洋生物科技园项目二期。公司公告汇总安琪酵母股份有限公司于2026年3月18日召开第十届董事会第十一次会议，审议通过多项议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","LU2148510915.USD","BK0028","BK0226","HBImain","LU1064131003.USD","BK0185","LU1064130708.USD","LU2580892862.HKD","600298","LU2580892789.USD","BK0175","159837"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620733247","title":"艾科联生物科技完成数千万美元融资 |【经纬低调新闻】","url":"https://stock-news.laohu8.com/highlight/detail?id=2620733247","media":"经纬创投","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620733247?lang=zh_cn&edition=full","pubTime":"2026-03-19 12:06","pubTimestamp":1773893160,"startTime":"0","endTime":"0","summary":"综述今日，专注于研发肿瘤与自身免疫性疾病下一代 T 细胞衔接器疗法的生物技术企业艾科联生物科技 宣布，公司已顺利完成超额认购的 6870 万美元融资。艾科联生物科技由方磊博士与朱杰伦先生联合创立。艾科联生物科技首创“中国式 NewCo”模式，整合连续创业家团队、优质管线资产与顶尖资本各核心要素，加速药物研发进程。目前，公司已迅速成长为一家聚焦下一代 TCE 疗法的多平台临床阶段的生物技术企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA3ODk5OTEzOA==&mid=2962187047&idx=2&sn=0355725ff34196e2d12bba68f7a9ce9c&chksm=ab6e3f36652f88018e812be9e1f5cf2932a3592d9796294fd50ce1d539e376eb04fae7ba78e5&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK4588","BK4585","XBI","159837","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620254652","title":"公告精选︱安琪酵母：宜昌高新区公司拟7.97亿元实施白洋生物科技园项目二期；顺灏股份：轨道辰光的“天数天算”业务可能在未来5年内才有明确的商业价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2620254652","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620254652?lang=zh_cn&edition=full","pubTime":"2026-03-18 22:00","pubTimestamp":1773842448,"startTime":"0","endTime":"0","summary":"沃森生物：拟向腾云新沃定增募资不超过20.03亿元","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4113413","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0028","BK0226","BK0185","BK4585","BK0222","LU1064130708.USD","LU2580892789.USD","BK0175","LU2580892862.HKD","XBI","BK4588","HBImain","BK0188","BK4581","LU2148510915.USD","600298","LU1064131003.USD","159837","002565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620323429","title":"安琪酵母最新公告：拟投建白洋生物科技园项目二期","url":"https://stock-news.laohu8.com/highlight/detail?id=2620323429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620323429?lang=zh_cn&edition=full","pubTime":"2026-03-18 18:19","pubTimestamp":1773829195,"startTime":"0","endTime":"0","summary":"安琪酵母(600298.SH)公告称，宜昌高新区公司拟实施白洋生物科技园项目二期，总投资7.97亿元。项目将建设年产12000吨高纯度酵母蛋白及联产产品核心技术攻关项目和年产20,000吨酵母蛋白及联产产品绿色制造项目。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800033248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","LU1064130708.USD","BK0175","LU2580892789.USD","BK0188","LU2148510915.USD","LU1064131003.USD","HBImain","600298","BK0185","159837","BK0028","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620473046","title":"步长制药（603858）披露控股子公司拟转让湖南众测生物科技60%股权公告，3月17日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620473046","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620473046?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:31","pubTimestamp":1773757874,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，步长制药报收于17.01元，较前一交易日上涨0.12%，最新总市值为179.38亿元。公告显示，公司控股子公司步长（广州）医学诊断技术有限公司拟将其持有的湖南众测生物科技有限公司60.00%股权以1.00元价格转让给杨福太。转让完成后，步长（广州）医学诊断不再直接或间接持有湖南众测及长沙众测生物科技有限公司股权。各方已签署股权转让协议，基准日为2025年12月31日，股权转让价款为1元，乙方应在协议签署后5个工作日内支付。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159837","HBImain","603858","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620433084","title":"港股异动 | 正大企业国际(03839)午后涨近14% 拟更名为“正大生物”生物科技业务贡献全部收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2620433084","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620433084?lang=zh_cn&edition=full","pubTime":"2026-03-17 13:59","pubTimestamp":1773727170,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，正大企业国际(03839)午后涨近14%，截至发稿，涨13.08%，报7.35港元，成交额405.29万港元。消息面上，正大企业国际公布，拟更名为“正大生物控股有限公司”。此次更名计划旨在更精准体现本公司目前的主营业务及未来的战略布局，进一步强化本公司致力成为世界领先的生物科技公司的愿景。据悉，公司目前的收入全部来自生物科技业务(动保兽药及金霉素产品)。值得注意的是，今年1月份，正大企业国际发布盈喜，预期2025年股东应占综合溢利约3200万美元，2024年同期则录得1120万美元。溢利增长主要由于收入的大幅增长，反映了公司成功地实施开发大客户销售关键策略。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","03839","HBImain","XBI","BK1212","VXUS","159837","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619888469","title":"华润医药(03320)：华润医药投资拟挂牌出售天麦生物科技约5.88%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2619888469","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619888469?lang=zh_cn&edition=full","pubTime":"2026-03-16 21:42","pubTimestamp":1773668550,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)公布，公司全资附属公司华润医药投资有限公司已启动潜在出售华润医药投资所持有合肥天麦生物科技发展有限公司(天麦生物科技)的约5.88%股权，其将通过上海联合产权交易所进行公开挂牌，初步挂牌底价约为人民币5.1亿元。潜在出售事项与华润医药投资及其附属公司出售天麦生物科技的若干股权属独立且互不相关的事项。于本公告日期，华润医药投资及其附属公司持有天麦生物科技约23.75%股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","HBImain","BK4585","BK1570","159837","BK4581","XBI","BK1191","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619163200","title":"新股消息 | 传生物科技初创公司Earendil Labs拟赴港IPO 融资规模或高达5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619163200","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619163200?lang=zh_cn&edition=full","pubTime":"2026-03-13 14:13","pubTimestamp":1773382386,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据媒体引述知情人士透露，生物科技初创公司Earendil Labs正在考虑在香港上市，正与中金公司和摩根士丹利着手安排股票发行，融资规模可能高达5亿美元。目前，Earendil、中金公司和摩根士丹利均未回应置评请求。合作项目上，Earendil与赛诺菲等企业合作，其中包括今年1月宣布的一项自身免疫及炎症疾病的合作项目。Earendil在2月与在香港上市的药明合联就癌症疗法技术达成协议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4581","159837","BK4585","BK4588","XBI","HBImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617500391","title":"香港交易所罗博仁：今年香港生物科技行业增长动力依然稳固","url":"https://stock-news.laohu8.com/highlight/detail?id=2617500391","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617500391?lang=zh_cn&edition=full","pubTime":"2026-03-06 15:16","pubTimestamp":1772781416,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港交易所证券产品发展主管罗博仁表示，生物科技为全球投资市场最备受关注的主题之一。今年香港生物科技行业的增长动力依然稳固，并反映于相关股份及整体板块表现之中。自2018年香港交易所推出上市制度改革以来，生物科技及医疗保健已成为香港市场中最活跃的板块之一。恒生生物科技指数期货于2025年11月在香港交易所推出，旨在扩阔投资者参与生物科技板块的渠道，同时提供有效的对冲工具。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0384037296.USD","LU0918141705.HKD","LU1226287529.USD","LU1504937902.USD","SG9999004220.SGD","HBImain","00388","LU0348816934.USD","LU0630378692.HKD","LU1642822792.SGD","LU0197773160.USD","LU0072913022.USD","LU0577902298.EUR","LU0417516902.SGD","LU1328277881.USD","LU2449936058.SGD","159837","LU1282648689.USD","LU0577902371.SGD","BK1610","LU1105468828.SGD","LU0516423174.USD","LU0052750758.USD","LU0955648018.USD","LU0516423091.SGD","LU1981816686.USD","HKXCY","BK4588","LU0651946864.USD","LU0819121731.USD","LU2039709279.SGD","SG9999002562.SGD","LU1044876610.USD","LU0251144936.SGD","LU2226246903.HKD","LU0607220059.USD","LU0261947096.USD","LABU","80388","LU0048580855.USD","IE00BZ08YR35.GBP","HEXmain","LU1211504680.USD","LU0791591158.USD","LU0955669360.SGD","IE00B3T34201.USD","LU0106959298.USD","LU0210527791.USD","LU0898667661.SGD","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779544712552,"stockEarnings":[{"period":"1week","weight":-0.0275},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0838},{"period":"6month","weight":-0.0893},{"period":"1year","weight":0.0022},{"period":"ytd","weight":-0.0709}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0076},{"period":"6month","weight":0.0725},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(159837)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(159837)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,159837,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(159837)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(159837)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}